|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||77.98 - 80.07|
|52 Week Range||60.14 - 83.88|
|Beta (3Y Monthly)||1.00|
|PE Ratio (TTM)||26.74|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||2.00 (2.52%)|
|1y Target Est||92.63|
John Sculley, RX Advance chairman and former CEO of Apple, joins 'Squawk Alley' to discuss how the healthcare industry is going to change following the midterm elections.
WOONSOCKET, R.I., Nov. 15, 2018 /PRNewswire/ -- CVS Health (CVS), the nation's first and only national pharmacy chain to have eliminated the sale of tobacco products from its retail stores, today announced its support for the U.S. Food and Drug Administration's plans to restrict access to flavored tobacco and e-cigarette products in the retail setting and impose stricter age-verification requirements for online sales. In addition to eliminating the sale of tobacco products in 2014, CVS Health has never sold e-cigarettes or vaping devices in any of its CVS Pharmacy locations. "We applaud the FDA's decision to restrict access to flavored tobacco and e-cigarette products, which have been expertly marketed and targeted at teens and young adults and has contributed to a dramatic rise in e-cigarette use among high school students," said Troyen Brennan, M.D., M.P.H. and Chief Medical Officer for CVS Health.
PHILADELPHIA, Nov. 15, 2018 /PRNewswire/ -- In its continuing commitment to expand work-based learning and externship opportunities for students, CVS Health has announced a new collaboration with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network to deliver a pre-apprenticeship and apprenticeship program for pharmacy technicians in the greater Philadelphia area.
Pot stocks and Apple lead the broad market decline. Institutions return to consumer-oriented stocks.
WOONSOCKET, R.I., Nov. 14, 2018 /PRNewswire/ -- Coram CVS Specialty® Home Infusion Services (Coram), a CVS Health (CVS) company, today announced it has earned The Joint Commission's Gold Seal of Approval® for Home Care Accreditation. The Gold Seal of Approval® is a symbol of quality that reflects Coram's commitment to providing safe and effective care. As part of the evaluation process, Coram underwent rigorous onsite surveys to ensure compliance with home care standards, including the provision of care, treatment and services, emergency management, human resources, among other standards.
Eighty-three percent of healthcare organizations responding to an American Telemedicine Association* poll said they are highly likely to invest in telehealth with operational efficiency and convenience in mind. Of the 171 healthcare executives participating in the annual ATA Executive Leadership Survey, 88% of those who are likely to purchase telehealth tools are planning to do so. "This executive leadership survey confirms undeniably today's leaders view telemedicine as a major driver in transforming healthcare," said Jonathan Linkous, CEO, American Telemedicine Association.
Walmart (WMT.N) and Home Depot (HD.N), two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards for everything from multiple sclerosis treatments to widely-used rheumatoid arthritis medications sold through a specialty pharmacy.
After Democrats obtained a narrow majority in the House of Representatives in the midterm elections, both House Democrats and President Trump will likely be looking to make at least some deals. To retain their majority, House Democrats will have to convince moderate voters in the swing districts that Democrats narrowly won that they are moderate and can be productive. For his part, President Trump will likely have to convince at least some moderate voters, i.e., centrist suburban women and independents that he can make deals that will make the country and their lives better.
The personal information of American charity donors, political party supporters, and online shoppers, has continued to quietly leak onto the internet as a result of poor website security practices, new research shows. As many as one in five e-commerce sites in the U.S. are still leaving their customers exposed, Philadelphia-based search marketing company Seer Interactive said Monday. "If you were one of the 50 largest e-commerce sites you’d think you’d have this under wraps, and that’s the most troubling thing," said Adam Melson, a director at Seer.
Value stocks are en vogue again. As recently as the end of May, stock prognosticators were calling for the Dow Jones Industrial Average to hit 30,000. Some suggested the Dow would reach that number by the end of 2018. Growth looked in, and slow-but-steady value picks were out. That was until October's bout of nauseating volatility. Thanks to a trade war with China, higher interest rates, problematic technology earnings and worries that a decade-long bull market is primed to lose its legs, the Nasdaq hit correction mode and the Standard & Poor's 500-stock index came close. Growth stocks - especially smaller companies - have been hammered, while large-cap value stocks have gained favor among investors looking for a little protection to go with their upside potential. Here are 10 large value stocks to buy now, with the expectation that they should thrive compared to their growthy brethren in a tumultuous environment. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond
With this in mind, a number of public companies are getting actively involved in capturing early market share including Premier Health Group, Inc. (PHGRF) (PHGI), CVS Health (CVS) and Allscripts (MDRX). Premier Health Group, Inc. (PHGRF) (PHGI) entered the primary care clinic and healthcare technology business via the HealthVue transaction. Premier obtained access to a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.
In the last CVS Health earnings report before its Aetna takeover closes, the drugstore and pharmacy benefit manager giant edged past views. CVS stock rose.
Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.
CVS Health (CVS) posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock. RBC increased its target price to $100 per share on CVS from $99. Meanwhile, Baird raised the target price to $77 from $73. Analysts have a consensus target price of $89.55 per share on CVS, which indicates an upside potential of 15.0% based on its closing price of $77.90 on November 6.
CVS Health (CVS) maintained its streak of exceeding Wall Street analysts’ bottom-line expectation during the third quarter. CVS posted adjusted earnings of $1.73, which beat analysts’ estimate of $1.71 and increased 15.3% on a YoY (year-over-year) basis. The following graph shows that CVS has reported better-than-expected earnings for five consecutive quarters.
CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion, which beat analysts’ estimate of $47.2 billion and increased 2.4% on a YoY (year-over-year) basis. Increased net new business, the growing adoption of Maintenance Choice offerings, brand inflation, and higher same-store prescription volumes drove the company’s third-quarter net sales growth.
WOONSOCKET, R.I., Nov. 7, 2018 /PRNewswire/ -- A new MinuteClinic walk-in medical clinic has opened inside the CVS Pharmacy store at 1900 19th Avenue in San Francisco, California, providing the community with convenient access to common health care services. The clinic is the first MinuteClinic location in the city of San Francisco and will be open seven days a week with no appointment necessary. MinuteClinic is the retail medical clinic of CVS Health (CVS), the largest pharmacy health care provider in the United States.
CVS Health (CVS) reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates due to the strong comp script growth, higher drug prices, and growth in claim volumes. However, pricing and reimbursement pressure remained a drag.